One blood test for many cancers? study tests it in High-Risk people
NCT ID NCT06450171
Summary
This study is testing a blood test called Galleri that aims to detect many types of cancer early. It will enroll 1,000 adults who are at higher-than-average risk due to a genetic condition or strong family history of cancer. Researchers will follow participants for up to 3 years to see how well the test finds cancer, what happens after a positive result, and how it affects people's anxiety and healthcare costs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER PREDISPOSITION SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.